These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 26481569)

  • 1. Response to Letter Regarding Article, "Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease".
    Navar-Boggan AM; Peterson ED; D'Agostino RB; Neely B; Sniderman AD; Pencina MJ
    Circulation; 2015 Oct; 132(16):e203. PubMed ID: 26481569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coronary arteriosclerosis and lipid metabolism (hyperlipemia)].
    Nakamura H
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():69-74. PubMed ID: 12734955
    [No Abstract]   [Full Text] [Related]  

  • 3. Tuberous xanthomata and coronary artery disease associated with hyperlipidemia.
    Shao C; Xu W; Chen J; Zhao L; Stella PR
    J Am Coll Cardiol; 2011 Nov; 58(23):2427. PubMed ID: 22115651
    [No Abstract]   [Full Text] [Related]  

  • 4. Small LDL and hsCRP as new risk factors for coronary artery disease.
    Brown CL; Garrett B; Superko HR
    J Med Assoc Ga; 2001 Dec; 90(4):11-6. PubMed ID: 11845678
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical aspects of dyslipidemia.
    Kashyap M
    Manag Care; 2001 Nov; 10(11 Suppl):4-9; discussion 19-24. PubMed ID: 11761628
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lipid metabolism and risk of myocardial infarction -- new findings and implications for treatment].
    Cullen P; Schulte H; Assmann G
    Dtsch Med Wochenschr; 2005 Sep; 130(39):2220-5. PubMed ID: 16189760
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperlipidemia, blood coagulation factors, hereditary familial factors and coronary atherosclerosis].
    Penco M; Del Porto G; Dagianti A
    Cardiologia; 1991 Dec; 36(12 Suppl 1):15-23. PubMed ID: 1841765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Sweat" and "greasy" blood as risk factors for coronary artery disease.
    Deeg M
    Cardiol Rev; 2003; 11(5):245-6. PubMed ID: 12943598
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B.
    Stein EA; Sniderman A; Laskarzewski P
    Am J Cardiol; 2005 Nov; 96(9A):36K-43K; discussion 34K-35K. PubMed ID: 16291013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary artery disease in patients with diabetes mellitus and its treatment].
    Teramoto T
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():94-9. PubMed ID: 11989270
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperlipidemia and coronary heart disease].
    Brugger P
    Wien Med Wochenschr; 1990 Jul; 140(14):382, 384-6. PubMed ID: 2219944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure.
    Sueta CA; Massing MW; Chowdhury M; Biggs DP; Simpson RJ
    J Card Fail; 2003 Feb; 9(1):36-41. PubMed ID: 12612871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerosis: who gets it and how it gets there.
    Ducas J
    Can J Cardiol; 1993 Mar; 9(2):160-1. PubMed ID: 8490785
    [No Abstract]   [Full Text] [Related]  

  • 14. [Coronary atherosclerosis and hyperlipidemia].
    Nakamura H
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):90-4. PubMed ID: 12436511
    [No Abstract]   [Full Text] [Related]  

  • 15. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach.
    Aikawa M; Libby P
    Cardiovasc Pathol; 2004; 13(3):125-38. PubMed ID: 15081469
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of the patient with ideal LDL cholesterol].
    Mendoza Pérez E
    Arch Cardiol Mex; 2003; 73 Suppl 1():S98-102. PubMed ID: 12966655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia.
    Nakamura T; Kodama Y; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Kitta Y; Kobayashi T; Mende A; Kugiyama K
    Atherosclerosis; 2007 Aug; 193(2):449-51. PubMed ID: 16997309
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipids and primary prevention of coronary disease].
    Idzior-Waluś B
    Przegl Lek; 1998; 55(2):77-84. PubMed ID: 9695648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
    Barter PJ; Ballantyne CM; Carmena R; Castro Cabezas M; Chapman MJ; Couture P; de Graaf J; Durrington PN; Faergeman O; Frohlich J; Furberg CD; Gagne C; Haffner SM; Humphries SE; Jungner I; Krauss RM; Kwiterovich P; Marcovina S; Packard CJ; Pearson TA; Reddy KS; Rosenson R; Sarrafzadegan N; Sniderman AD; Stalenhoef AF; Stein E; Talmud PJ; Tonkin AM; Walldius G; Williams KM
    J Intern Med; 2006 Mar; 259(3):247-58. PubMed ID: 16476102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperlipidemia: decreasing lipid values and effects of statins].
    Mathes P
    Z Kardiol; 2002; 91 Suppl 2():25-9. PubMed ID: 12436762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.